Company intelligence / Profile preview
NeuroTherapia, Inc.
Cleveland, Ohio, United Statesneurotherapia.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NeuroTherapia has completed Phase I trials demonstrating safety and favorable pharmacokinetics for its lead molecule NTRX‑07. Early data suggest a trend toward cognitive improvement in Alzheimer’s patients. The company has initiated a Phase 2a trial to further assess efficacy and biomarker impact. Preclinical work supports the mechanism of reducing neuroinflammation via selective CB2 receptor agonism without psychoactive effects typical of cannabinoids. Additional preclinical programs are being developed for other CNS/neurodegenerative conditions including Parkinson's, ALS, and pain syndromes related to neuroinflammation
- Therapeutic areas
- Neurology
- Modalities
- Small molecules (oral)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Cleveland Clinic Innovations (founding partner/investor)Brain Trust Accelerator Fund II [investor/partner]Dolby Family Ventures [investor/partner]Alzheimer’s Drug Discovery Foundation [ADDF] [investor/grant partner]
Beyond the preview
Go deeper on NeuroTherapia, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeuroTherapia, Inc..